Exposure to perinatal morphine promotes developmental changes in rat striatum

Alfredo Gorio, Maria Luisa Malosio, Letizia Vergani, A. M D Giulio

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This study shows that perinatal exposure to morphine promotes developmental changes (up to 8 months of life) in the striatum by up-regulating concentrations of substance P and met-enkephalin with changes of prometenkephalin A mRNA expression at the day of birth only. Dopamine metabolism (up to 60 days) is also increased as suggested by the reduced concentrations of dopamine and increased content of 3,4-dihydroxyphenylacetic acid. Tyrosine hydroxylase mRNA expression is selectively reduced only in the substantia nigra by perinatal morphine. Serotonin content is reduced only during the early postnatal days and is unaffected thereafter. Supplementation of naltrexone to morphine-exposed rats prevents monoaminergic and neuropeptidergic changes in the striatum, which directly implicates opioid receptors in the developmental changes caused by morphine. The data suggest that perinatal morphine may inhibit met-enkephalin release, causing accumulation of the peptide without corresponding changes in specific mRNA. Dopamine release may also be increased as indicated by a higher metabolism and consequent reduction of tyrosine hydroxylase mRNA expression in the substantia nigra.

Original languageEnglish
Pages (from-to)471-479
Number of pages9
JournalInternational Journal of Developmental Neuroscience
Volume14
Issue number4
DOIs
Publication statusPublished - Jul 1996

Fingerprint

Morphine
Dopamine
Methionine Enkephalin
Messenger RNA
Tyrosine 3-Monooxygenase
Substantia Nigra
3,4-Dihydroxyphenylacetic Acid
Naltrexone
Opioid Receptors
Substance P
Serotonin
Parturition
Peptides

Keywords

  • Dopamine
  • Met-enkephalin
  • Morphine
  • Opioid receptor
  • Serotonin
  • Substance P
  • Tyrosine hydroxylase

ASJC Scopus subject areas

  • Developmental Biology
  • Developmental Neuroscience

Cite this

Exposure to perinatal morphine promotes developmental changes in rat striatum. / Gorio, Alfredo; Malosio, Maria Luisa; Vergani, Letizia; Giulio, A. M D.

In: International Journal of Developmental Neuroscience, Vol. 14, No. 4, 07.1996, p. 471-479.

Research output: Contribution to journalArticle

@article{b1e8debc0e9640fe98da451c9f79d49e,
title = "Exposure to perinatal morphine promotes developmental changes in rat striatum",
abstract = "This study shows that perinatal exposure to morphine promotes developmental changes (up to 8 months of life) in the striatum by up-regulating concentrations of substance P and met-enkephalin with changes of prometenkephalin A mRNA expression at the day of birth only. Dopamine metabolism (up to 60 days) is also increased as suggested by the reduced concentrations of dopamine and increased content of 3,4-dihydroxyphenylacetic acid. Tyrosine hydroxylase mRNA expression is selectively reduced only in the substantia nigra by perinatal morphine. Serotonin content is reduced only during the early postnatal days and is unaffected thereafter. Supplementation of naltrexone to morphine-exposed rats prevents monoaminergic and neuropeptidergic changes in the striatum, which directly implicates opioid receptors in the developmental changes caused by morphine. The data suggest that perinatal morphine may inhibit met-enkephalin release, causing accumulation of the peptide without corresponding changes in specific mRNA. Dopamine release may also be increased as indicated by a higher metabolism and consequent reduction of tyrosine hydroxylase mRNA expression in the substantia nigra.",
keywords = "Dopamine, Met-enkephalin, Morphine, Opioid receptor, Serotonin, Substance P, Tyrosine hydroxylase",
author = "Alfredo Gorio and Malosio, {Maria Luisa} and Letizia Vergani and Giulio, {A. M D}",
year = "1996",
month = "7",
doi = "10.1016/0736-5748(95)00106-9",
language = "English",
volume = "14",
pages = "471--479",
journal = "International Journal of Developmental Neuroscience",
issn = "0736-5748",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Exposure to perinatal morphine promotes developmental changes in rat striatum

AU - Gorio, Alfredo

AU - Malosio, Maria Luisa

AU - Vergani, Letizia

AU - Giulio, A. M D

PY - 1996/7

Y1 - 1996/7

N2 - This study shows that perinatal exposure to morphine promotes developmental changes (up to 8 months of life) in the striatum by up-regulating concentrations of substance P and met-enkephalin with changes of prometenkephalin A mRNA expression at the day of birth only. Dopamine metabolism (up to 60 days) is also increased as suggested by the reduced concentrations of dopamine and increased content of 3,4-dihydroxyphenylacetic acid. Tyrosine hydroxylase mRNA expression is selectively reduced only in the substantia nigra by perinatal morphine. Serotonin content is reduced only during the early postnatal days and is unaffected thereafter. Supplementation of naltrexone to morphine-exposed rats prevents monoaminergic and neuropeptidergic changes in the striatum, which directly implicates opioid receptors in the developmental changes caused by morphine. The data suggest that perinatal morphine may inhibit met-enkephalin release, causing accumulation of the peptide without corresponding changes in specific mRNA. Dopamine release may also be increased as indicated by a higher metabolism and consequent reduction of tyrosine hydroxylase mRNA expression in the substantia nigra.

AB - This study shows that perinatal exposure to morphine promotes developmental changes (up to 8 months of life) in the striatum by up-regulating concentrations of substance P and met-enkephalin with changes of prometenkephalin A mRNA expression at the day of birth only. Dopamine metabolism (up to 60 days) is also increased as suggested by the reduced concentrations of dopamine and increased content of 3,4-dihydroxyphenylacetic acid. Tyrosine hydroxylase mRNA expression is selectively reduced only in the substantia nigra by perinatal morphine. Serotonin content is reduced only during the early postnatal days and is unaffected thereafter. Supplementation of naltrexone to morphine-exposed rats prevents monoaminergic and neuropeptidergic changes in the striatum, which directly implicates opioid receptors in the developmental changes caused by morphine. The data suggest that perinatal morphine may inhibit met-enkephalin release, causing accumulation of the peptide without corresponding changes in specific mRNA. Dopamine release may also be increased as indicated by a higher metabolism and consequent reduction of tyrosine hydroxylase mRNA expression in the substantia nigra.

KW - Dopamine

KW - Met-enkephalin

KW - Morphine

KW - Opioid receptor

KW - Serotonin

KW - Substance P

KW - Tyrosine hydroxylase

UR - http://www.scopus.com/inward/record.url?scp=0030198828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030198828&partnerID=8YFLogxK

U2 - 10.1016/0736-5748(95)00106-9

DO - 10.1016/0736-5748(95)00106-9

M3 - Article

C2 - 8884380

AN - SCOPUS:0030198828

VL - 14

SP - 471

EP - 479

JO - International Journal of Developmental Neuroscience

JF - International Journal of Developmental Neuroscience

SN - 0736-5748

IS - 4

ER -